285 related articles for article (PubMed ID: 30093402)
21. Indolent ALK-negative anaplastic large-cell lymphoma, DUSP22 rearranged, with an unusual immunophenotype in a human immunodeficiency virus patient.
Chapman J; Vega F
Histopathology; 2017 Jun; 70(7):1173-1175. PubMed ID: 28042680
[No Abstract] [Full Text] [Related]
22. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.
Feldman AL; Dogan A; Smith DI; Law ME; Ansell SM; Johnson SH; Porcher JC; Ozsan N; Wieben ED; Eckloff BW; Vasmatzis G
Blood; 2011 Jan; 117(3):915-9. PubMed ID: 21030553
[TBL] [Abstract][Full Text] [Related]
23. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
[TBL] [Abstract][Full Text] [Related]
24.
Onaindia A; de Villambrosía SG; Prieto-Torres L; Rodríguez-Pinilla SM; Montes-Moreno S; González-Vela C; Piris MA
Haematologica; 2019 Apr; 104(4):e158-e162. PubMed ID: 30361415
[No Abstract] [Full Text] [Related]
25. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
[TBL] [Abstract][Full Text] [Related]
26. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
[TBL] [Abstract][Full Text] [Related]
27. Genetic Subtypes of Systemic Anaplastic Large Cell Lymphoma Show Distinct Differences in PD-L1 Expression and Regulatory and Cytotoxic T Cells in the Tumor Microenvironment.
Ferreira CR; Manohar V; Zhao S; Bangs CD; Cherry A; Azevedo RS; Lage LAPC; Pereira J; Zerbini MCN; Gratzinger D; Natkunam Y
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):10-16. PubMed ID: 31809310
[TBL] [Abstract][Full Text] [Related]
28. "Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.
Karube K; Feldman AL
Blood; 2020 Feb; 135(9):700. PubMed ID: 32106310
[No Abstract] [Full Text] [Related]
29. Genetics of anaplastic large cell lymphoma.
Zeng Y; Feldman AL
Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084
[TBL] [Abstract][Full Text] [Related]
30. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
Anderson J; Putnam E; Liu W; Menon MP
Int J Lab Hematol; 2022 Feb; 44(1):67-68. PubMed ID: 34019742
[No Abstract] [Full Text] [Related]
31. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
Boddicker RL; Feldman AL
Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
[No Abstract] [Full Text] [Related]
32. Recurrent
Luchtel RA; Zimmermann MT; Hu G; Dasari S; Jiang M; Oishi N; Jacobs HK; Zeng Y; Hundal T; Rech KL; Ketterling RP; Lee JH; Eckloff BW; Yan H; Gaonkar KS; Tian S; Ye Z; Kadin ME; Sidhu J; Jiang L; Voss J; Link BK; Syrbu SI; Facchetti F; Bennani NN; Slager SL; Ordog T; Kocher JP; Cerhan JR; Ansell SM; Feldman AL
Blood; 2019 Jun; 133(26):2776-2789. PubMed ID: 31101622
[TBL] [Abstract][Full Text] [Related]
33.
Savage KJ; Slack GW
Haematologica; 2023 Jun; 108(6):1463-1467. PubMed ID: 36453106
[No Abstract] [Full Text] [Related]
34. Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.
Kutok JL; Aster JC
J Clin Oncol; 2002 Sep; 20(17):3691-702. PubMed ID: 12202671
[TBL] [Abstract][Full Text] [Related]
35. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
36. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
Yuan CT; Cheng AL; Hou HA
Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
Zhang Y; Chen M; Yu Y; Liu X; Liu W; Jiang L; Zhang W
J Cutan Pathol; 2022 Feb; 49(2):187-190. PubMed ID: 34622970
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic large cell lymphomas with the 6p25.3 rearrangement are a heterogeneous group of tumours with a diverse molecular background.
Díaz de la Pinta FJ; Rodríguez Moreno M; Salgado RN; Carvajal García N; Santonja C; Pérez Buira S; Piris MA; Requena L; Manso R; Rodríguez-Pinilla SM
Hum Pathol; 2023 Jul; 137():71-78. PubMed ID: 37127078
[TBL] [Abstract][Full Text] [Related]
39.
Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Ketterling RP; Bedroske PP; Luoma IM; Sattler CA; Boddicker RL; Bennani NN; Nørgaard P; Møller MB; Steiniche T; d'Amore F; Feldman AL
Blood; 2017 Jul; 130(4):554-557. PubMed ID: 28522440
[No Abstract] [Full Text] [Related]
40. Primary cutaneous CD30+ lymphoproliferative disorders with DUSP22 translocation.
Montes-Moreno S
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):136-139. PubMed ID: 38010388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
